Feb 28 (Reuters) - Pharmacy benefit manager Catamaran Corp
reported a 59 percent jump in fourth-quarter
profit, but the company's forecast for the year and the lack of
clarity on its deal pipeline dampened investor sentiment.

Shares of Catamaran, formerly named SXC Health Solutions,
fell as much as 7 percent to C$52.81 on Thursday on the Toronto
Stock Exchange. The stock has gained 20 percent since the
beginning of the year, outperforming the benchmark S&P/TSX
composite index.

"If you look at how the stock was trading prior to the
release of the results, I think the market might have been
expecting a little bit more in terms of the guidance," analyst
Gabriel Leung of Paradigm Capital said.

Leung said Catamaran's forecast factored in deals they have
already signed, so the company could increase its outlook over
the course of the year if it signs additional deals.
Continued...